Amy Witkoski Stimpfel

Faculty

Amy Witkoski Stimpfel Headshot

Amy Witkoski Stimpfel

PhD RN

Assistant Professor

1 212 992 9387

433 First Ave
New York, NY 10010
United States

Accepting PhD students

Amy Witkoski Stimpfel's additional information

Amy Witkoski Stimpfel is an assistant professor at NYU Rory Meyers College of Nursing and the Program Director of the doctoral training program in occupational and environmental health nursing, part of the NY/NJ ERC, funded by the National Institute for Occupational Safety and Health (NIOSH) (T42-OH-008422). Broadly, her research expertise centers on how to optimize nurses’ work environments to improve nurse well-being and clinical outcomes. Specifically, her program of research seeks to identify how the organization of work related to shift work, scheduling, and sleep influences nurses’ health and well-being, patient safety, and organizational outcomes. Her scholarship is rooted in theories and methods used in health services research, occupational health and safety, sleep/circadian science, and nursing. Dr. Witkoski Stimpfel’s research has been funded by the American Nurses Foundation, the National Council of State Boards of Nursing, and others and published in leading interprofessional journals such as Health Affairs, Health Services Research, and The International Journal of Nursing Studies. Prior to joining the Meyers faculty, Dr. Witkoski Stimpfel completed a post-doctoral fellowship at the University of Pennsylvania in the Center for Health Outcomes and Policy Research. Dr. Witkoski Stimpfel earned a PhD and MS at the University of Pennsylvania and a BSN, cum laude, from Villanova University.

PhD - University of Pennsylvania (2011)
MS - University of Pennsylvania (2009)
BSN - Villanova University (Cum Laude, 2006)

Nursing workforce
Health Services Research

AcademyHealth
American Association of Occupational Health Nurses
American Nurses Association
Eastern Nursing Research Society
Sigma Theta Tau International
Sleep Research Society

Faculty Honors Awards

Excellence in Nursing Research Award (2022)
Connelly-Delouvrier Scholarship for International Nursing in Ireland
At-large member, Advisory Committee of the Interdisciplinary Research Group on Nursing Issues (IRGNI)
Inducted into Sigma Theta Tau International Honor Society
T01 Pre-doctoral fellowship, National Institute for Occupational Safety and Health
T32 Post-doctoral fellowship, National Institute of Nursing Research

Publications

How differing shift lengths relate to quality outcomes in pediatrics

Stimpfel, A. W., Lake, E. T., Barton, S., Gorman, K. C., & Aiken, L. H. (2013). Journal of Nursing Administration, 43(2), 95-100. 10.1097/NNA.0b013e31827f2244
Abstract
Abstract
Objective:: The aims of this study were to describe the shift lengths of pediatric nurses and to measure the association of shift length with nurse job outcomes, nurse-reported patient outcomes, and nurse-assessed safety and quality of care in hospitals. Background:: Long work hours have been linked with poor patient outcomes in adult patient populations, but little is known about the relationship in pediatric settings. Methods:: A secondary analysis of cross-sectional nurse survey data was conducted. Our analysis focused on 3710 registered nurses who worked in 342 acute care hospitals that treated children. Results:: Most pediatric nurses worked 12-hour shifts, especially in intensive care settings. Nurses who worked extended shifts of more than 13 hours reported worse job outcomes and lower quality and safety for patients compared with nurses who worked 8-hour shifts. Conclusions:: Allocating resources to nursing to improve working hours may be a productive strategy for administrators to improve the health and well-being of pediatric patients and nurses.

The longer the shifts for hospital nurses, the higher the levels of burnout and patient dissatisfaction

Stimpfel, A. W., Sloane, D. M., & Aiken, L. H. (2012). Health Affairs, 31(11), 2501-2509. 10.1377/hlthaff.2011.1377
Abstract
Abstract
Extended work shifts of twelve hours or longer are common and even popular with hospital staff nurses, but little is known about how such extended hours affect the care that patients receive or the wellbeing of nurses. Survey data from nurses in four states showed that more than 80 percent of the nurses were satisfied with scheduling practices at their hospital. However, as the proportion of hospital nurses working shifts of more than thirteen hours increased, patients' dissatisfaction with care increased. Furthermore, nurses working shifts of ten hours or longer were up to two and a half times more likely than nurses working shorter shifts to experience burnout and job dissatisfaction and to intend to leave the job. Extended shifts undermine nurses' well-being, may result in expensive job turnover, and can negatively affect patient care. Policies regulating work hours for nurses, similar to those set for resident physicians, may be warranted. Nursing leaders should also encourage workplace cultures that respect nurses' days off and vacation time, promote nurses' prompt departure at the end of a shift, and allow nurses to refuse to work overtime without retribution.

Nurse reported quality of care: A measure of hospital quality

McHugh, M. D., & Stimpfel, A. W. (2012). Research in Nursing and Health, 35(6), 566-575. 10.1002/nur.21503
Abstract
Abstract
As the primary providers of round-the-clock bedside care, nurses are well positioned to report on hospital quality of care. Researchers have not examined how nurses' reports of quality correspond with standard process or outcomes measures of quality. We assess the validity of evaluating hospital quality by aggregating hospital nurses' responses to a single item that asks them to report on quality of care. We found that a 10% increment in the proportion of nurses reporting excellent quality of care was associated with lower odds of mortality and failure to rescue; greater patient satisfaction; and higher composite process of care scores for acute myocardial infarction, pneumonia, and surgical patients. Nurse reported quality of care is a useful indicator of hospital performance.

Social Cognitive and Clinical Factors Associated with HPV Vaccine Initiation Among Urban, Economically Disadvantaged Women

Teitelman, A. M., Stringer, M., Nguyen, G. T., Hanlon, A. L., Averbuch, T., & Stimpfel, A. W. (2011). JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing, 40(6), 691-701. 10.1111/j.1552-6909.2011.01297.x
Abstract
Abstract
Objective: To learn more about human papilloma virus (HPV) knowledge and vaccination among teens and young women age 13 to 26 years from an economically disadvantaged, urban community. Our aim was to identify common beliefs about HPV vaccine initiation and describe the relationship between attitudes, norms, perceived control, and intention to receive HPV vaccine, drawing from the theory of planned behavior (TPB). Design: Mixed method, descriptive design. Guided by the TPB, HPV vaccine beliefs were assessed through focus groups. Intention to receive the vaccine, demographic and clinical factors, and theoretical predictor variables (attitudes, norms, and control) were assessed through questionnaires. Setting: After recruitment, focus groups were held at a convenient date and time for our participants in a small university conference room. Participants: Participants were economically disadvantaged young women, age 13 to 26 (N = 34). Methods: Specific behavioral, normative, and control beliefs were elicited in focus groups and analyzed using content analysis. Simple and multivariate general linear modeling with adjustment for prognostic demographic and clinical factors was completed to assess the influence of the theoretical predictor variables on the outcome of HPV vaccine initiation. Results: Influential beliefs toward vaccination were identified. Analysis indicated attitudes, norms, and perceived control toward HPV vaccine initiation were highly significant predictors of intent, as was tobacco use; all p's < .001. Conclusion: Barriers to HPV vaccine initiation were identified, and strong preliminary evidence supports use of the TPB to guide programs to promote urban, economically disadvantaged young women's intent to begin the HPV vaccine.

Hospital staff nurses' work hours, meal periods, and rest breaks. A review from an occupational health nurse perspective.

Witkoski, A., & Dickson, V. V. (2010). AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses, 58(11), 489-497; quiz 498. 10.1177/216507991005801106
Abstract
Abstract
Registered nurses are the largest group of health care providers in the United States. To provide 24-hour care, hospital staff nurses often work long hours and consecutive shifts, without adequate meal or rest breaks. Serious declines in functioning related to provider fatigue can lead to safety issues for patients and nurses alike. The occupational health nurse can assess the effects of nurses' work hours and break periods on employee health, educate staff on the importance of sleep and deleterious effects of fatigue, and implement programs to improve the work environment. This article examines nurses' work hours, break and meal period laws and regulations, and the role of the occupational health nurse in caring for this group of employees. Overall findings suggest that the expertise of an occupational health nurse in the hospital setting could significantly improve the health and safety of staff nurses.

Human papillomavirus, current vaccines, and cervical cancer prevention

Teitelman, A. M., Stringer, M., Averbuch, T., & Witkoski, A. (2009). JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing, 38(1), 69-80. 10.1111/j.1552-6909.2008.00304.x
Abstract
Abstract
Human papillomavirus infection, the most common sexually transmitted infection in the United States, is associated with the development of cervical cancer. The new human papillomavirus vaccine advances cervical cancer prevention; however, provider-recommended screening with Papanicolaou tests and lifestyle modifications are still needed. Widespread implementation of the vaccine and delivering cervical cancer screening to underserved populations remain a challenge. Nurses are ideally suited to address these needs by providing education to patients and families.

Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor

Witters, L. M., Witkoski, A., Planas-Silva, M. D., Berger, M., Viallet, J., & Lipton, A. (2007). Oncology Reports, 17(2), 465-469. 10.3892/or.17.2.465
Abstract
Abstract
The epidermal growth factor receptor (EGFR) (ErbB1) and HER-2/neu (ErbB2) are members of the ErbB family of receptor tyrosine kinases. These receptors are overexpressed in a variety of human tumors and overexpression generally correlates with poor prognosis and decreased survival. Lapatinib, a reversible inhibitor of both EGFR and HER-2/neu, has shown some success in achieving clinical responses in heavily pretreated advanced cancer patients. GW2974 is a reversible dual inhibitor similar to lapatinib, but GW2974 was not progressed to clinical trials due to pharmacokinetic issues. Bcl-2, an anti-apoptotic protein, is also overexpressed in a number of human tumors. Bcl-2 inhibitors induce apoptosis and sensitize cancer cells to other therapies. The purpose of this study was to assess the effects of combining ErbB and Bcl-2 inhibitors on the growth of human breast cancer cell lines. EGFR/HER-2/neu tyrosine kinase inhibitors (lapatinib and GW2974) were combined with Bcl-2 inhibitors (HA14-1 or GX15-070) and the anti-proliferative effects were determined by the MTT tetrazolium dye assay. Combinations were tested in MCF-7 human breast cancer cells, a HER-2/neu transfected MCF-7 cell line (MCF/18), and a tamoxifen-resistant MCF-7 cell line (MTR-3). A synergistic inhibitory effect was observed with the combination of inhibitors of EGFR-HER-2/neu (lapatinib or GW2974) and Bcl-2 (GX15-070 or HA14-1) on the growth of the MCF-7, MCF/18, and MTR-3 human breast cancer cell lines. This study suggests that simultaneously blocking the ErbB family of receptor tyrosine kinases and Bcl-2 family of proteins may be a benefit to breast cancer patients.